The primary goal of the recently renamed Functional Genomics and Microbiome Core (Core C) is to enhance research programs in infection and injury states affecting the mammalian intestine and liver by providing genomics and metagenomics expertise and resources. In this Core, we utilize advanced technology in mammalian and microbial genomics to support ongoing and innovative research to prevent and cure digestive diseases. This Core enables investigators to posit research questions related to gene expression, functional genomics and molecular mechanisms by utilizing the tools of microarrays, deep nucleic acid sequencing (microbial and mammalian), nucleic acid amplification, protein profiling, and bioinformatics. PCR based analyses of gene expression and splicing, DNA mutation/SNP detection, and gene pathway analyses ofthe mammalian metagenome (microbe and man) will be fostered by this Core as a platform for gastrointestinal and hepatic systems biology. Our mission is to provide a full service resource from experimental design to consultations about specimen processing, robust data analysis pipelines, and biostatistical support. In summary, we have created a fully integrated genomic analysis platform for investigators studying digestive diseases.

Public Health Relevance

This Core provides help with complex molecular technologies such as gene expression profiling and genomic microarray analyses, complex protein bead assays, metagenomic sequencing and microbiome analyses needed by DDC members.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Baylor College of Medicine
United States
Zip Code
Desai, Moreshwar S; Eblimit, Zeena; Thevananther, Sundararajah et al. (2015) Cardiomyopathy reverses with recovery of liver injury, cholestasis and cholanemia in mouse model of biliary fibrosis. Liver Int 35:1464-77
Khalaf, N; Ramsey, D; Kramer, J R et al. (2015) Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus 28:283-90
Kou, Baijun; Crawford, Sue E; Ajami, Nadim J et al. (2015) Characterization of cross-reactive norovirus-specific monoclonal antibodies. Clin Vaccine Immunol 22:160-7
Shakhatreh, Mohammad H; Duan, Zhigang; Avila, Nathaniel et al. (2015) Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol 13:280-6
El-Serag, Hashem B; Kanwal, Fasiha; Davila, Jessica A et al. (2014) A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology 146:1249-55.e1
Gould-Suarez, Milena; El-Serag, Hashem B; Musher, Benjamin et al. (2014) Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci 59:2913-26
Darkoh, Charles; Comer, Latoya; Zewdie, Getie et al. (2014) Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One 9:e93144
Katayama, Kazuhiko; Murakami, Kosuke; Sharp, Tyler M et al. (2014) Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A 111:E4043-52
Horiuchi, Akira; Graham, David Y (2014) Special topics in procedural sedation: clinical challenges and psychomotor recovery. Gastrointest Endosc 80:404-9
Mayer, Emeran A; Savidge, Tor; Shulman, Robert J (2014) Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146:1500-12

Showing the most recent 10 out of 611 publications